Showing 581 - 600 results of 18,664 for search '(( 50 ((ns decrease) OR (we decrease)) ) OR ( 59 ((mean decrease) OR (a decrease)) ))', query time: 0.95s Refine Results
  1. 581
  2. 582
  3. 583
  4. 584
  5. 585
  6. 586
  7. 587
  8. 588

    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity by Xiao-Meng Liu (778197)

    Published 2023
    “…Among them, compound <b>10</b> exhibited a 118-fold enhancement in the IC<sub>50</sub> value compared to cisplatin and low toxicity to normal cells. …”
  9. 589

    Optical coherence tomography findings. by Eisuke Usui (12111855)

    Published 2024
    “…After PCI, hDPV significantly increased from 55.6 cm/s to 69.5 cm/s (P<0.01), with a median %hDPV increase of 27.2 (6.32–59.1) %, while %hDPV decreased in 20 (19.4%) patients. …”
  10. 590

    S1 Data - by Eisuke Usui (12111855)

    Published 2024
    “…After PCI, hDPV significantly increased from 55.6 cm/s to 69.5 cm/s (P<0.01), with a median %hDPV increase of 27.2 (6.32–59.1) %, while %hDPV decreased in 20 (19.4%) patients. …”
  11. 591

    Clinical demographics and angiographic findings. by Eisuke Usui (12111855)

    Published 2024
    “…After PCI, hDPV significantly increased from 55.6 cm/s to 69.5 cm/s (P<0.01), with a median %hDPV increase of 27.2 (6.32–59.1) %, while %hDPV decreased in 20 (19.4%) patients. …”
  12. 592

    Physiological parameters. by Eisuke Usui (12111855)

    Published 2024
    “…After PCI, hDPV significantly increased from 55.6 cm/s to 69.5 cm/s (P<0.01), with a median %hDPV increase of 27.2 (6.32–59.1) %, while %hDPV decreased in 20 (19.4%) patients. …”
  13. 593
  14. 594

    <i>TERT-CLPTM1L</i> Rs401681 C>T Polymorphism Was Associated with a Decreased Risk of Esophageal Cancer in a Chinese Population by Jun Yin (94374)

    Published 2014
    “…</p><p>Results</p><p>When the <i>TERT-CLPTM1L</i> rs401681 CC homozygote genotype was used as the reference group, the CT genotype was associated with a significantly decreased risk of ESCC (adjusted OR  = 0.74, 95% CI  = 0.58–0.94, <i>p</i> = 0.012); the CT/TT variants were associated with a 26% decreased risk of ESCC (adjusted OR  = 0.74, 95% CI  = 0.59–0.93, <i>P</i> = 0.009). …”
  15. 595
  16. 596

    A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized... by Yuejun Liu (800012)

    Published 2015
    “…</p><p>Results</p><p>Four-month treatment with the dietary supplement decreased FPG compared to placebo (-0.24±0.50 <i>vs</i> +0.12±0.59 mmol/L, respectively, p = 0.02), without detectable significant changes in HbA1c. …”
  17. 597
  18. 598
  19. 599
  20. 600

    Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom? by Patrick Berkovic (808056)

    Published 2015
    “…</b> The average GTV reduction was 42.1% (range 4.0–69.3%); 50.1% and 33.7% for the cCRT and sCRT patients, respectively. …”